Kamada Ltd. (KMDA) News Nov 20, 2014, 4:00 p.m. M
Post# of 250602
Posted On: 11/20/2014 10:11:54 PM
Kamada Ltd. (KMDA) News Nov 20, 2014, 4:00 p.m.
MarketWatch News on KMDA
No News currently available for KMDA
Other News on KMDA
3 Stocks Pushing The Drugs Industry Lower 3:32 p.m. Nov. 13, 2014 - TheStreet.com
Israeli Biotech Stocks Offer Low Returns For High Risk Investment 7:12 a.m. Oct. 3, 2014 - Seeking Alpha
Kamada extends Glassia supply agreement 12:56 p.m. Sept. 29, 2014 - Seeking Alpha
Investors Should Exercise Caution With REVO Biologics IPO 7:22 a.m. Sept. 16, 2014 - Seeking Alpha
Silver Spring Networks Starts The Week Strong 12:30 p.m. Sept. 8, 2014 - TheStreet.com
Kamada Plunges Following Missed Marks In Trial 11:52 a.m. Sept. 4, 2014 - TheStreet.com
Kamada AATD therapeutic fails in clinical trial 6:35 a.m. Sept. 4, 2014 - Seeking Alpha
Kamada updates revenue guidance after Q2 results 9:02 a.m. Aug. 14, 2014 - Seeking Alpha
Should You Get Rid of Kamada (KMDA) Now? - Tale of the Tape 7:34 a.m. July 11, 2014 - Zacks.com
Weekly 3-Year Low Highlights: FMS, SNOW, KMDA, LAYN 4:55 p.m. June 16, 2014 - GuruFocus.com
Should You Get Rid of Kamada (KMDA) Now? - Tale of the Tape 7:53 a.m. May 20, 2014 - Zacks.com
Kamada reports mixed results in AAT trial 6:42 a.m. May 16, 2014 - Seeking Alpha
Kamada Enters Oversold Territory (KMDA) 10:59 a.m. May 8, 2014 - TheStreet.com
Omni Bio Raises Cash, Wastes No Time Getting Back To Work 10:14 a.m. May 2, 2014 - Seeking Alpha
Why You Need to Pay Attention to Kamada (KMDA) Stock? - Tale of the Tape 9:00 a.m. March 7, 2014 - Zacks.com
Six Israeli Biotech New Issues Set A Blistering Pace 5:12 p.m. Jan. 14, 2014 - Investors Business Daily
Biotech Investor Realism With Andrew Fein 12:36 p.m. Sept. 4, 2013 - Seeking Alpha
7 Biotechnology Stocks to Buy Now 9:45 a.m. Aug. 7, 2013 - InvestorPlace.com
Kamada's CEO Discusses Q2 2013 Results - Earnings Call Transcript 6:16 p.m. Aug. 2, 2013 - Seeking Alpha
Press Releases on KMDA
Kamada Announces Third Quarter 2014 Financial Results 7:03 a.m. Nov. 12, 2014 - BusinessWire - BZX
Kamada to Host Third Quarter 2014 Financial Results Conference Call on November 12, 2014 7:01 a.m. Nov. 10, 2014 - BusinessWire - BZX
FDA Grants Kamada Orphan Drug Designation for the Treatment of Graft versus Host Disease 7:36 a.m. Oct. 29, 2014 - BusinessWire - BZX
Kamada Announces Study in Support of Alpha-1 Antitrypsin for the Treatment of Type-1 Diabetes Published in the Journal of Diabetes Science and Technology 6:00 a.m. Oct. 21, 2014 - BusinessWire - BZX
Kamada Announces Second Extension of Strategic Agreement with Baxter 5:30 a.m. Sept. 29, 2014 - BusinessWire - BZX
Kamada to Announce Final Results from Phase 2/3 Clinical TrialofInhaled AAT to Treat Alpha-1 Antitrypsin Deficiency on September 4, 2014 3:29 p.m. Sept. 3, 2014 - BusinessWire - BZX
Kamada Reports Second Quarter Financial Results 7:03 a.m. Aug. 14, 2014 - BusinessWire - BZX
Kamada to Host Second Quarter Financial Results Conference Call on Thursday, August 14, 2014 6:00 a.m. Aug. 6, 2014 - BusinessWire - BZX
Kamada Announces Preliminary Results from Phase II/III Pivotal Trial in Europe and Canada of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency 6:31 a.m. May 16, 2014 - BusinessWire - BZX
Kamada to Announce Results from Phase 2/3 Clinical TrialofInhaled AAT to Treat Alpha-1 Antitrypsin Deficiency on May 16 12:31 a.m. May 15, 2014 - BusinessWire - BZX
Kamada Reports First Quarter Financial Results 6:41 a.m. May 8, 2014 - BusinessWire - BZX
Kamada Announces Significantly Improved Infusion Rate for Glassia® 7:05 a.m. April 24, 2014 - BusinessWire - BZX
Kamada Announces U.S. Proof-of-Concept Study with Glassia® for Graft-Versus-Host Disease 6:01 a.m. April 3, 2014 - BusinessWire - BZX
Kamada Announces Initiation of a Phase 2 U.S. Clinical Trial of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency 6:01 a.m. March 24, 2014 - BusinessWire - BZX
Outbrain Appoints Ziv Kop As COO 12:30 p.m. March 21, 2014 - PR Newswire - PRF
Kamada to Report Top-Line Data from Phase 2/3 Clinical Trial of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency by Late April or Early May 6:01 a.m. March 21, 2014 - BusinessWire - BZX
Kamada Initiates Phase 2/3 Clinical Trial of Glassia to Treat Newly Diagnosed Pediatric Patients with Type 1 Diabetes 7:01 a.m. March 5, 2014 - BusinessWire - BZX
Kamada Completes Enrollment in U.S. Pivotal Clinical Trial with KamRAB as a Post-Exposure Treatment for Rabies 8:04 a.m. March 4, 2014 - BusinessWire - BZX
Kamada Ltd. [KMDA] to Ring The NASDAQ Stock Market Opening Bell 10:00 a.m. Feb. 24, 2014 - GlobeNewswire
Kamada to Ring The NASDAQ Stock Market Opening Bell on February 25, 2014 8:31 a.m. Feb. 24, 2014 - BusinessWire - BZX
MarketWatch News on KMDA
No News currently available for KMDA
Other News on KMDA
3 Stocks Pushing The Drugs Industry Lower 3:32 p.m. Nov. 13, 2014 - TheStreet.com
Israeli Biotech Stocks Offer Low Returns For High Risk Investment 7:12 a.m. Oct. 3, 2014 - Seeking Alpha
Kamada extends Glassia supply agreement 12:56 p.m. Sept. 29, 2014 - Seeking Alpha
Investors Should Exercise Caution With REVO Biologics IPO 7:22 a.m. Sept. 16, 2014 - Seeking Alpha
Silver Spring Networks Starts The Week Strong 12:30 p.m. Sept. 8, 2014 - TheStreet.com
Kamada Plunges Following Missed Marks In Trial 11:52 a.m. Sept. 4, 2014 - TheStreet.com
Kamada AATD therapeutic fails in clinical trial 6:35 a.m. Sept. 4, 2014 - Seeking Alpha
Kamada updates revenue guidance after Q2 results 9:02 a.m. Aug. 14, 2014 - Seeking Alpha
Should You Get Rid of Kamada (KMDA) Now? - Tale of the Tape 7:34 a.m. July 11, 2014 - Zacks.com
Weekly 3-Year Low Highlights: FMS, SNOW, KMDA, LAYN 4:55 p.m. June 16, 2014 - GuruFocus.com
Should You Get Rid of Kamada (KMDA) Now? - Tale of the Tape 7:53 a.m. May 20, 2014 - Zacks.com
Kamada reports mixed results in AAT trial 6:42 a.m. May 16, 2014 - Seeking Alpha
Kamada Enters Oversold Territory (KMDA) 10:59 a.m. May 8, 2014 - TheStreet.com
Omni Bio Raises Cash, Wastes No Time Getting Back To Work 10:14 a.m. May 2, 2014 - Seeking Alpha
Why You Need to Pay Attention to Kamada (KMDA) Stock? - Tale of the Tape 9:00 a.m. March 7, 2014 - Zacks.com
Six Israeli Biotech New Issues Set A Blistering Pace 5:12 p.m. Jan. 14, 2014 - Investors Business Daily
Biotech Investor Realism With Andrew Fein 12:36 p.m. Sept. 4, 2013 - Seeking Alpha
7 Biotechnology Stocks to Buy Now 9:45 a.m. Aug. 7, 2013 - InvestorPlace.com
Kamada's CEO Discusses Q2 2013 Results - Earnings Call Transcript 6:16 p.m. Aug. 2, 2013 - Seeking Alpha
Press Releases on KMDA
Kamada Announces Third Quarter 2014 Financial Results 7:03 a.m. Nov. 12, 2014 - BusinessWire - BZX
Kamada to Host Third Quarter 2014 Financial Results Conference Call on November 12, 2014 7:01 a.m. Nov. 10, 2014 - BusinessWire - BZX
FDA Grants Kamada Orphan Drug Designation for the Treatment of Graft versus Host Disease 7:36 a.m. Oct. 29, 2014 - BusinessWire - BZX
Kamada Announces Study in Support of Alpha-1 Antitrypsin for the Treatment of Type-1 Diabetes Published in the Journal of Diabetes Science and Technology 6:00 a.m. Oct. 21, 2014 - BusinessWire - BZX
Kamada Announces Second Extension of Strategic Agreement with Baxter 5:30 a.m. Sept. 29, 2014 - BusinessWire - BZX
Kamada to Announce Final Results from Phase 2/3 Clinical TrialofInhaled AAT to Treat Alpha-1 Antitrypsin Deficiency on September 4, 2014 3:29 p.m. Sept. 3, 2014 - BusinessWire - BZX
Kamada Reports Second Quarter Financial Results 7:03 a.m. Aug. 14, 2014 - BusinessWire - BZX
Kamada to Host Second Quarter Financial Results Conference Call on Thursday, August 14, 2014 6:00 a.m. Aug. 6, 2014 - BusinessWire - BZX
Kamada Announces Preliminary Results from Phase II/III Pivotal Trial in Europe and Canada of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency 6:31 a.m. May 16, 2014 - BusinessWire - BZX
Kamada to Announce Results from Phase 2/3 Clinical TrialofInhaled AAT to Treat Alpha-1 Antitrypsin Deficiency on May 16 12:31 a.m. May 15, 2014 - BusinessWire - BZX
Kamada Reports First Quarter Financial Results 6:41 a.m. May 8, 2014 - BusinessWire - BZX
Kamada Announces Significantly Improved Infusion Rate for Glassia® 7:05 a.m. April 24, 2014 - BusinessWire - BZX
Kamada Announces U.S. Proof-of-Concept Study with Glassia® for Graft-Versus-Host Disease 6:01 a.m. April 3, 2014 - BusinessWire - BZX
Kamada Announces Initiation of a Phase 2 U.S. Clinical Trial of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency 6:01 a.m. March 24, 2014 - BusinessWire - BZX
Outbrain Appoints Ziv Kop As COO 12:30 p.m. March 21, 2014 - PR Newswire - PRF
Kamada to Report Top-Line Data from Phase 2/3 Clinical Trial of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency by Late April or Early May 6:01 a.m. March 21, 2014 - BusinessWire - BZX
Kamada Initiates Phase 2/3 Clinical Trial of Glassia to Treat Newly Diagnosed Pediatric Patients with Type 1 Diabetes 7:01 a.m. March 5, 2014 - BusinessWire - BZX
Kamada Completes Enrollment in U.S. Pivotal Clinical Trial with KamRAB as a Post-Exposure Treatment for Rabies 8:04 a.m. March 4, 2014 - BusinessWire - BZX
Kamada Ltd. [KMDA] to Ring The NASDAQ Stock Market Opening Bell 10:00 a.m. Feb. 24, 2014 - GlobeNewswire
Kamada to Ring The NASDAQ Stock Market Opening Bell on February 25, 2014 8:31 a.m. Feb. 24, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼